China approves first domestic mRNA COVID-19 vaccine
Briefly

In a study of 4,000 participants, the vaccine showed efficacy of 85.3 percent 14 to 28 days after a booster vaccination.China has approved its first domestically developed mRNA vaccine against COVID-19, its manufacturer said on Wednesday, months after the relaxation of strict zero-COVID regulations sparked a surge in cases.
Read at www.aljazeera.com
[
add
]
[
|
|
]